Literature DB >> 25524670

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non-small cell lung cancer.

Brendon M Stiles1, Michael Schulster2, Abu Nasar2, Subroto Paul2, Paul C Lee2, Jeffrey L Port2, Nasser K Altorki2.   

Abstract

OBJECTIVE: We sought to define the prevalence, malignancy rate, and outcome of secondary nodules (SNs) detected on computed tomography (CT) scan for patients undergoing resection for primary non-small cell lung cancer (NSCLC).
METHODS: In consecutive patients with NSCLC, we reviewed all CT scan reports obtained at diagnosis of the dominant tumor for description of SNs. When resected, pathology was reviewed. Serial CT reports for 2 years postoperatively were evaluated to follow SNs not resected.
RESULTS: Among 155 patients, 88 (57%) were found to have SNs. A total of 137 SNs were evaluated (median size, 0.5 cm). Thirty-two nodules were resected at primary resection. Nineteen (61%) resected nodules were benign, whereas 13 (39%) were malignant (8 synchronous primary tumors and 5 lobar metastases). A total of 105 unresected nodules were followed by CT. Of these, 32 (30%) resolved completely, 20 (19%) shrunk, and 28 (27%) were stable, whereas 11 (11%) were lost to follow-up. Fourteen SNs (13%) grew, of which 5 were found to be malignant, each a new primary. Overall 5-year survival was not different between patients with or without SNs (67% vs 64%; P = .88). DISCUSSION: The prevalence of SNs on CT scan in patients undergoing resection for primary NSCLC is high. Only a low proportion of SNs are ever found to be malignant, predominantly those on the ipsilateral side as the dominant tumor. The presence of SNs has no effect on survival. Patients with SNs, if otherwise appropriately staged, should not be denied surgical therapy.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25524670     DOI: 10.1016/j.jtcvs.2014.10.057

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Say goodbye to Martini and Melamed: genomic classification of multiple synchronous lung cancer.

Authors:  Brendon M Stiles
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

2.  Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503.

Authors:  Leslie J Kohman; Lin Gu; Nasser Altorki; Ernest Scalzetti; Linda J Veit; Jason M Wallen; Xiaofei Wang
Journal:  J Thorac Cardiovasc Surg       Date:  2017-02-07       Impact factor: 5.209

3.  Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung.

Authors:  Ping-Chung Tsai; Chia Liu; Yi-Chen Yeh; Chun-Ku Chen; Po-Kuei Hsu; Hui-Shan Chen; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Biing-Shiun Huang
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

4.  Surveillance of the Remaining Nodules after Resection of the Dominant Lung Adenocarcinoma is an Appropriate Follow-Up Strategy.

Authors:  Massimo Castiglioni; Brian E Louie; Candice L Wilshire; Alexander S Farivar; Ralph W Aye; Jed Gorden; Matthew P Horton; Eric Vallières
Journal:  Front Surg       Date:  2015-01-12

5.  Coexistent Non-Small Cell Carcinoma and Small Cell Carcinoma in a Patient Presenting with Hyponatremia.

Authors:  Mitchell D Ross; Sreeja Biswas Roy; Pradnya D Patil; Jasmine L Huang; Nitika Thawani; Ralph Drosten; Tanmay S Panchabhai
Journal:  Case Rep Pulmonol       Date:  2018-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.